Xiaoli Xu, An-Tian Chen, Yantao Ding, Tingting Zhu, Luyao Xia, Jingkai Xu, Liyue Sun, Lu Liu
{"title":"探讨系统性红斑狼疮与2019冠状病毒病之间的复杂关系:遗传见解和潜在的保护机制。","authors":"Xiaoli Xu, An-Tian Chen, Yantao Ding, Tingting Zhu, Luyao Xia, Jingkai Xu, Liyue Sun, Lu Liu","doi":"10.7189/jogh.15.04191","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Severe coronavirus disease 2019 (COVID-19) and systemic lupus erythematosus (SLE) have been reported to share common gene loci, but the causal relationship between them remains controversial.</p><p><strong>Methods: </strong>We conducted a linkage disequilibrium score regression analysis to assess the genetic correlations between SLE and the two traits (infection and severity) of COVID-19 in European populations. Mendelian randomisation analysis was then performed to explore the causal effect of SLE on susceptibility to these traits in both European and East Asian data sets. Lastly, enrichment analysis and Protein-Protein Interactions analysis were used to identify key pathways and genes involved, providing insights into the possible mechanism underlying the complex relationship between SLE and COVID-19.</p><p><strong>Results: </strong>A significant genetic correlation was observed between SLE and COVID-19 severity (genetic correlation (rg) = 0.340, P = 0.001). However, no significant genetic correlation was found with COVID-19 infection. Mendelian randomisation analysis revealed a negative causal effect of SLE on both COVID-19 infection (odds ratio (OR) = 0.986; 95% confidence interval (CI) = 0.975-0.997, P = 0.009) and severity (OR = 0.955; 95% CI = 0.921-0.990, P = 0.012) in European populations, with similar findings replicated in East Asians. Notably, interleukin-6 (IL-6) and tumour necrosis factor were identified as hub cytokines connecting SLE to COVID-19 infection, while IL-6 and interleukin-10 (IL-10) were pivotal in connecting SLE to COVID-19 severity.</p><p><strong>Conclusions: </strong>This study reveals a potentially protective effect of SLE against COVID-19 infection and severity, with IL-6, tumour necrosis factor, and IL-10 playing key roles. Despite immunosuppressant use, SLE patients showed no increased risk of severe outcomes, likely due to their heightened caution in avoiding infection. These findings challenge common assumptions and highlight the need for further research.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04191"},"PeriodicalIF":4.3000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12247663/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the complex relationship between systemic lupus erythematosus and coronavirus disease 2019: genetic insights and potential protective mechanisms.\",\"authors\":\"Xiaoli Xu, An-Tian Chen, Yantao Ding, Tingting Zhu, Luyao Xia, Jingkai Xu, Liyue Sun, Lu Liu\",\"doi\":\"10.7189/jogh.15.04191\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Severe coronavirus disease 2019 (COVID-19) and systemic lupus erythematosus (SLE) have been reported to share common gene loci, but the causal relationship between them remains controversial.</p><p><strong>Methods: </strong>We conducted a linkage disequilibrium score regression analysis to assess the genetic correlations between SLE and the two traits (infection and severity) of COVID-19 in European populations. Mendelian randomisation analysis was then performed to explore the causal effect of SLE on susceptibility to these traits in both European and East Asian data sets. Lastly, enrichment analysis and Protein-Protein Interactions analysis were used to identify key pathways and genes involved, providing insights into the possible mechanism underlying the complex relationship between SLE and COVID-19.</p><p><strong>Results: </strong>A significant genetic correlation was observed between SLE and COVID-19 severity (genetic correlation (rg) = 0.340, P = 0.001). However, no significant genetic correlation was found with COVID-19 infection. Mendelian randomisation analysis revealed a negative causal effect of SLE on both COVID-19 infection (odds ratio (OR) = 0.986; 95% confidence interval (CI) = 0.975-0.997, P = 0.009) and severity (OR = 0.955; 95% CI = 0.921-0.990, P = 0.012) in European populations, with similar findings replicated in East Asians. Notably, interleukin-6 (IL-6) and tumour necrosis factor were identified as hub cytokines connecting SLE to COVID-19 infection, while IL-6 and interleukin-10 (IL-10) were pivotal in connecting SLE to COVID-19 severity.</p><p><strong>Conclusions: </strong>This study reveals a potentially protective effect of SLE against COVID-19 infection and severity, with IL-6, tumour necrosis factor, and IL-10 playing key roles. Despite immunosuppressant use, SLE patients showed no increased risk of severe outcomes, likely due to their heightened caution in avoiding infection. These findings challenge common assumptions and highlight the need for further research.</p>\",\"PeriodicalId\":48734,\"journal\":{\"name\":\"Journal of Global Health\",\"volume\":\"15 \",\"pages\":\"04191\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12247663/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Global Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7189/jogh.15.04191\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Global Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7189/jogh.15.04191","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
摘要
背景:据报道,2019年严重冠状病毒病(COVID-19)和系统性红斑狼疮(SLE)具有共同的基因位点,但两者之间的因果关系仍存在争议。方法:通过连锁不平衡评分回归分析,评估欧洲人群中SLE与COVID-19两种特征(感染和严重程度)之间的遗传相关性。然后进行孟德尔随机化分析,在欧洲和东亚数据集中探讨SLE对这些特征易感性的因果关系。最后,利用富集分析和蛋白-蛋白相互作用分析确定了关键途径和相关基因,为SLE和COVID-19之间复杂关系的可能机制提供了见解。结果:SLE与COVID-19严重程度存在显著的遗传相关(遗传相关(rg) = 0.340, P = 0.001)。但与COVID-19感染没有明显的遗传相关性。孟德尔随机化分析显示SLE对COVID-19感染的负因果效应(优势比(OR) = 0.986;95%置信区间(CI) = 0.975 ~ 0.997, P = 0.009)和严重程度(OR = 0.955;95% CI = 0.921-0.990, P = 0.012),在东亚人群中也有类似的发现。值得注意的是,白细胞介素-6 (IL-6)和肿瘤坏死因子被确定为SLE与COVID-19感染相关的枢纽细胞因子,而白细胞介素-6和白细胞介素-10 (IL-10)是SLE与COVID-19严重程度相关的关键细胞因子。结论:本研究揭示SLE对COVID-19感染和严重程度具有潜在的保护作用,其中IL-6、肿瘤坏死因子和IL-10起关键作用。尽管使用了免疫抑制剂,SLE患者出现严重后果的风险并未增加,这可能是由于他们在避免感染方面更加谨慎。这些发现挑战了普遍的假设,并强调了进一步研究的必要性。
Exploring the complex relationship between systemic lupus erythematosus and coronavirus disease 2019: genetic insights and potential protective mechanisms.
Background: Severe coronavirus disease 2019 (COVID-19) and systemic lupus erythematosus (SLE) have been reported to share common gene loci, but the causal relationship between them remains controversial.
Methods: We conducted a linkage disequilibrium score regression analysis to assess the genetic correlations between SLE and the two traits (infection and severity) of COVID-19 in European populations. Mendelian randomisation analysis was then performed to explore the causal effect of SLE on susceptibility to these traits in both European and East Asian data sets. Lastly, enrichment analysis and Protein-Protein Interactions analysis were used to identify key pathways and genes involved, providing insights into the possible mechanism underlying the complex relationship between SLE and COVID-19.
Results: A significant genetic correlation was observed between SLE and COVID-19 severity (genetic correlation (rg) = 0.340, P = 0.001). However, no significant genetic correlation was found with COVID-19 infection. Mendelian randomisation analysis revealed a negative causal effect of SLE on both COVID-19 infection (odds ratio (OR) = 0.986; 95% confidence interval (CI) = 0.975-0.997, P = 0.009) and severity (OR = 0.955; 95% CI = 0.921-0.990, P = 0.012) in European populations, with similar findings replicated in East Asians. Notably, interleukin-6 (IL-6) and tumour necrosis factor were identified as hub cytokines connecting SLE to COVID-19 infection, while IL-6 and interleukin-10 (IL-10) were pivotal in connecting SLE to COVID-19 severity.
Conclusions: This study reveals a potentially protective effect of SLE against COVID-19 infection and severity, with IL-6, tumour necrosis factor, and IL-10 playing key roles. Despite immunosuppressant use, SLE patients showed no increased risk of severe outcomes, likely due to their heightened caution in avoiding infection. These findings challenge common assumptions and highlight the need for further research.
期刊介绍:
Journal of Global Health is a peer-reviewed journal published by the Edinburgh University Global Health Society, a not-for-profit organization registered in the UK. We publish editorials, news, viewpoints, original research and review articles in two issues per year.